NDR family

Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).

GtoImmuPdb view: ON   

Overview

« Hide More detailed introduction

LATS1 and LATS1 are core components of the Hippo pathway, which is essentially a kinase cascade whose terminal output regulates the activities of specific transcriptional coactivators which control expression of a diverse set of genes that are involved in cell proliferation, survival, and migration. Hippo signalling has traditionally been viewed as a key regulator of organ growth and development, tissue homeostasis and tumour suppression in multiple organisms [4]. More recent studies have identified new roles for the Hippo pathway in immunology [2-3,5].

Enzymes

Targets of relevance to immunopharmacology are highlighted in blue

LATS1 (large tumor suppressor kinase 1) Show summary » More detailed page

LATS2 (large tumor suppressor kinase 2) Show summary » More detailed page

NDR1 (Serine/threonine kinase 38) Show summary » More detailed page

NDR2 (Serine/threonine kinase 38 like) Show summary » More detailed page

References

Show »

How to cite this family page

Database page citation:

NDR family. Accessed on 25/09/2018. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=587.

Concise Guide to PHARMACOLOGY citation:

Alexander SPH, Fabbro D, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators. (2017) The Concise Guide to PHARMACOLOGY 2017/18: Enzymes. Br J Pharmacol. 174 Suppl 1: S272-S359.